QVAR 40
BECLOMETHASONE DIPROPIONATE
Approval overview QVAR 40 is listed in Drugs@FDA under application 020911 (NDA).
Review priority: STANDARD Marketing status: Discontinued Active ingredient BECLOMETHASONE DIPROPIONATE Form and strength AEROSOL, METERED;INHALATION - 0.04MG/INH **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** Sponsor TEVA BRANDED PHARM Submission history Latest submission status date: 2017-09-29 00:00:00.
Structured Monograph
Clinical summary
Approval overview QVAR 40 is listed in Drugs@FDA under application 020911 (NDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient BECLOMETHASONE DIPROPIONATE Form and strength AEROSOL, METERED;INHALATION - 0.04MG/INH **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** Sponsor TEVA BRANDED PHARM Submission history Latest submission status date: 2017-09-29 00:00:00. Submission type: SUPPL.
Monitoring
- • Marketing status: Discontinued
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.